Legend Biotech (LEGN) Profit After Tax (2019 - 2025)
Legend Biotech (LEGN) posted Profit After Tax of $30.9 million for Q4 2025, up 177.86% on a QoQ basis from -$39.7 million in Q3 2025, and up 17.05% year-over-year from $26.4 million in Q4 2024.
Legend Biotech (LEGN) has 7 years of Profit After Tax data on file, last reported at $30.9 million in Q4 2025.
- In Q4 2025, Profit After Tax rose 17.05% year-over-year to $30.9 million; the TTM figure through Dec 2025 stood at -$235.1 million (down 32.88% YoY), while the FY2025 annual figure was $296.8 million, up 67.68% from the prior year.
- Profit After Tax rose to $30.9 million in Q4 2025, from -$39.7 million in the prior quarter.
- Across five years, Profit After Tax topped out at $30.9 million in Q4 2025 and bottomed at -$199.1 million in Q2 2023.
- A 5-year average of -$76.8 million and a median of -$86.6 million in 2021 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax slumped 35570.18% — and 2024, when it jumped 18329.78%.
- Year by year, Profit After Tax stood at -$88.3 million in 2021, then plunged by 53.82% to -$135.9 million in 2022, then soared by 99.89% to -$144818.0 in 2023, then jumped by 18329.78% to $26.4 million in 2024, then rose by 17.05% to $30.9 million in 2025.
- The last three Profit After Tax figures came in at $30.9 million (Q4 2025), -$39.7 million (Q3 2025), and -$125.4 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -453.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.90 Mn |
| Sep 30, 2025 | -39.69 Mn |
| Jun 30, 2025 | -125.38 Mn |
| Mar 31, 2025 | -100.92 Mn |
| Dec 31, 2024 | 26.40 Mn |
| Sep 30, 2024 | -125.32 Mn |
| Jun 30, 2024 | -18.20 Mn |
| Mar 31, 2024 | -59.79 Mn |
| Dec 31, 2023 | -144,818.00 |
| Sep 30, 2023 | -62.21 Mn |
| Jun 30, 2023 | -199.13 Mn |
| Mar 31, 2023 | -112.10 Mn |
| Dec 31, 2022 | -135.88 Mn |
| Sep 30, 2022 | -84.96 Mn |
| Jun 30, 2022 | -193.23 Mn |
| Mar 31, 2022 | -32.29 Mn |
| Dec 31, 2021 | -88.33 Mn |
| Sep 30, 2021 | -124.75 Mn |
| Jun 30, 2021 | -91.58 Mn |
| Mar 31, 2021 | -90,521.00 |
| Dec 31, 2020 | -57.83 Mn |
| Sep 30, 2020 | -66.55 Mn |
| Jun 30, 2020 | -134.88 Mn |
| Mar 31, 2020 | -44.23 Mn |
| Dec 31, 2019 | -63.94 Mn |
| Sep 30, 2019 | -27.80 Mn |
| Jun 30, 2019 | -28.80 Mn |